FDA tightens clinical requirements for transvaginal devices

Jan 4 (Reuters) - The U.S. Food and Drug Administration said on Monday it had taken steps to strengthen the data requirements for surgical mesh devices when used to repair pelvic organ prolapse (POP) via the vagina.